Otarmeni Gene Therapy

Otarmeni Gene Therapy

In 2026, Children’s Wisconsin became the first hospital in the United States to provide the newly approved OtarmeniTM (lunsotogene parvec-cwha) gene therapy outside of a clinical trial. This groundbreaking treatment for hearing loss is approved for children with certain types of genetic hearing loss.